Corrigendum to "Review on biofilms and the currently available antibiofilm approaches: Matrix-destabilizing hydrolases and anti-bacterial peptides as promising candidates for the food industries' [Int. J. Biol. Macromol. Volume 219, 31 October 2022, pages 1163-1179].
Biofilm problems aren’t just a headache for hospitals—food companies deal with them too. Antibacterial peptides are grabbing attention as a smart way to break down stubborn biofilms and keep surfaces clean. A new corrigendum published in the International Journal of Biological Macromolecules highlights the latest thinking on how matrix-destabilizing hydrolases and peptides could transform biofilm management in the food industry.
Int J Biol Macromol
by Akbarian M, Chen SH, Kianpour M et al.
“Corrigendum to "Review on biofilms and the currently available antibiofilm approaches: Matrix-destabilizing hydrolases and anti-bacterial peptides as promising candidates for the food industries' [Int. J. Biol. Macromol. Volume 219, 31 October 2022, pages 1163-1179]. Akbarian M(1), Chen SH(2), Kianpour M(3), Farjadian F(4), Tayebi L(5), Uversky VN(6). Author information: (1)Department of Chemistry, National Cheng Kung University, Tainan, 701, Taiwan. Electronic address: Mohsen.akbarian66@gmail.com. (2)Department of Chemistry, National Cheng Kung University, Tainan, 701, Taiwan. (3)Institute of Biomedical Sciences, National Sun Yat-sen University, Kaohsiung, Taiwan. (4)Pharmaceutical Sciences Research Center, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran. (5)School of Dentistry, Marquette University, Milwaukee, WI, USA. (6)Department of Molecular Medicine and Health Byrd Alzheimer's Institute, Morsani College of Medicine, University of South Florida, Tampa, FL, USA; Laboratory of New Methods in Biology, Institute for Biological Instrumentation of the Russian Academy of Sciences, Federal Research Center "Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences", Pushchino, Moscow region, Russia. Electronic address: vuversky@health.usf.edu. Erratum for Int J Biol Macromol. 2022 Oct 31;219:1163-1179. doi: 10.1016/j.ijbiomac.2022.08.192.”
Key takeaway: Antibacterial peptides are finally getting their due as real contenders for biofilm control. The original review by Akbarian and colleagues mapped out how these peptides, along with enzymes that break down biofilm matrices, can disrupt bacterial communities that stick to equipment and food surfaces. Food safety researchers have been looking for alternatives to harsh chemicals. Peptides, with their targeted action and lower risk of resistance, fit the bill.
Here’s why this matters:
Foodborne biofilms are tough to kill and can lead to contamination.
Standard disinfectants don’t always work—bacteria in biofilms are protected by a sticky matrix.
Antibacterial peptides attack bacteria directly and can destabilize that matrix, making other cleaning steps more effective.
The correction itself is technical—mostly about author details and affiliations. But the core idea stands: Peptide research is a hot spot for anyone trying to keep food processing safe and efficient. Researchers in this field should keep an eye out for new peptide-based solutions and enzyme combos.
Want more on how peptides are moving research forward? Browse the peptide research index for the latest updates. Sourcing peptides for your own lab work? Check out the vendor directory.
Peptides aren’t just for the future—they’re making an impact now.
Related Reading
Eu(3+)-mediated dual-crosslinked collagen-mimetic peptide/sodium alginate hydrogel for 3D-printed skin wound dressings.
News · Acta BiomaterAntimicrobial-potentiated colorectal cancer therapy with synchronized tumoricidal immunity via a self-deliverable nanopeptide.
News · J Am Pharm Assoc (2003)Real-world weight impact upon tirzepatide discontinuation at a single-center endocrinology clinic in patients with overweight or obesity.
For Research Use Only
All content published on Pushing Peptides is intended for educational and informational purposes only. The information provided is not intended as medical advice, diagnosis, or treatment. Peptides discussed in this article are research compounds and are not approved for human therapeutic use by the FDA or any other regulatory agency. All studies referenced involve animal models or in vitro research unless otherwise stated. Consult a qualified healthcare professional before making any decisions related to your health. Pushing Peptides does not sell peptides — we are a vendor directory and educational resource.